Opioid overdoses claimed nearly 70,000 lives in 2017. Unless something is done to deflect this toxic trajectory, the death toll could exceed 500,000 over the next decade. How can we successfully confront this public health menace?
Individuals may start using opioids for medical or recreational purposes. The risk of addiction increases when:
opioids are used with other drugs,
opioids are prescribed at higher doses than is medically appropriate, or
opioids are used recreationally.
Treatment can help users who become addicted. Opioid misuse increases the risk of multiple harms, including car accidents, health problems, dependence, and fatal or non-fatal overdose. RAND work presents a comprehensive view of this dynamic crisis, highlighting which stage a policy is designed to address and noting when policies focused on one stage may have unintended consequences elsewhere.
Increasing access to medications like methadone and buprenorphine is essential to addressing the U.S. opioid crisis. But the severity of the crisis warrants examining additional interventions. What does the evidence suggest about heroin-assisted treatment and supervised consumption sites? And what are some of the issues associated with implementing them in the United States?
Researchers conducted a series of interviews with key informants in four countries—Canada, the Netherlands, Switzerland, and the United Kingdom—to learn about their experiences with implementing heroin-assisted treatment and supervised consumption sites.
Researchers conducted a series of interviews and focus groups in areas hit hard by the opioid crisis to examine some of the issues associated with implementing heroin-assisted treatment and supervised consumption sites in the United States.